Nanoparticles and the blood coagulation system. Part II: safety concerns.
about
Nanoparticle Uptake: The Phagocyte ProblemKinetics of protein adsorption on gold nanoparticle with variable protein structure and nanoparticle size.Action of Nanoparticles on Platelet Activation and Plasmatic CoagulationEffect of nano-scale curvature on the intrinsic blood coagulation system.Cationic nanocarriers induce cell necrosis through impairment of Na(+)/K(+)-ATPase and cause subsequent inflammatory response.Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-Associated Fibroblast Activation.Silica Nanoparticles Effects on Blood Coagulation Proteins and PlateletsIn vivo Biocompatibility, Biodistribution and Therapeutic Efficiency of Titania Coated Upconversion Nanoparticles for Photodynamic Therapy of Solid Oral Cancers.Engineered nanoparticles: thrombotic events in cancer.Nanodiagnostics, nanopharmacology and nanotoxicology of platelet-vessel wall interactions.Transfection Studies with Colloidal Systems Containing Highly Purified Bipolar Tetraether Lipids from Sulfolobus acidocaldariusTuning Properties of Iron Oxide Nanoparticles in Aqueous Synthesis without Ligands to Improve MRI Relaxivity and SAR.Cathepsin S-cleavable, multi-block HPMA copolymers for improved SPECT/CT imaging of pancreatic cancerPlasma protein adsorption and biological identity of systemically administered nanoparticles.Developing a tissue glue by engineering the adhesive and hemostatic properties of metal oxide nanoparticles.Magnetic nanoparticles for drug targeting: from design to insights into systemic toxicity. Preclinical evaluation of hematological, vascular and neurobehavioral toxicology.Chondroitin sulfate coated gold nanoparticles: a new strategy to resolve multidrug resistance and thromboinflammation.Vascular biosafety of commercial hydroxyapatite particles: discrepancy between blood compatibility assays and endothelial cell behavior.Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems.Effects of acute systemic administration of TiO2, ZnO, SiO2, and Ag nanoparticles on hemodynamics, hemostasis and leukocyte recruitment.Determining the relationship between nanoparticle characteristics and immunotoxicity: key challenges and approaches.New Avenues for Nanoparticle-Related Therapies.Flow cytometric analysis of the physical and protein-binding characteristics of solid drug nanoparticle suspensionsBiologically Targeted Magnetic Hyperthermia: Potential and LimitationsImpact of functional inorganic nanotubes f-INTs-WS2 on hemolysis, platelet function and coagulation
P2860
Q28395287-B1541BAA-7B9E-4CBD-83BB-EEE63A5674BDQ30380907-1883CC26-A79F-4F41-BB73-81D415427EC2Q33600393-604965DC-294F-4F0E-ADF9-0B276503F8FAQ34473963-FF9E032E-6307-403C-B4A0-050B3FE5EAA2Q36293364-FB5A3E8B-F0E9-4B37-99D9-8E0245CB1FDFQ36531166-A00723E6-24A4-4A69-9F0F-CEAC1A9AF773Q36531517-23860862-F4CD-4074-A0E4-CC2E0C2F4D61Q37202303-933FD166-E722-471C-BC68-E82AC54DAA6FQ38262939-F1303D30-AFB8-4AAD-833A-00DB651297CEQ38495085-2FEF26FD-A430-4C1D-9C6E-20AE3A59FA2EQ38714756-55ADC480-8F3B-4CD9-B2EF-C1E1D5ADDD92Q41553384-FBC8FEBA-BC21-4955-AD0F-763A7719676FQ41634347-876DC813-F4E5-423A-85C5-34C1648CBAA6Q47570893-53381B53-C2F7-423B-8E98-7C86BEEC5DBEQ48027077-D8AF2532-2A4F-44A9-84CE-DBDD85E9A04DQ48168170-22EC9BAF-3585-4F0F-8012-D7CBA445F661Q50910495-DEE1F937-771F-4FEC-82FA-1A7E628F0558Q51732274-A4544EF0-9C2B-48CE-AA11-FA2C84AE6D57Q51739696-272984D6-1F2B-4786-803F-25356D01AE99Q53612925-41964B11-5417-43B9-9173-9CBCCDA33B94Q53755427-927BE0B7-713D-4E30-98DB-676ECC6E3464Q55452723-45960FD5-E5AA-4E94-8969-E61BC297F14AQ58073502-E42787AB-4A8C-47C2-9D9A-C927040D77A2Q58803377-D6DD734D-90C9-4F50-8761-9DFE26DAA46CQ59137851-FB7F50D8-6FB1-4D77-B29D-92DAAADE2054
P2860
Nanoparticles and the blood coagulation system. Part II: safety concerns.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@en
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@nl
type
label
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@en
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@nl
prefLabel
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@en
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@nl
P2860
P356
P1433
P1476
Nanoparticles and the blood coagulation system. Part II: safety concerns.
@en
P2093
Anna N Ilinskaya
Marina A Dobrovolskaia
P2860
P304
P356
10.2217/NNM.13.49
P577
2013-06-01T00:00:00Z